Fecal Microbiota Transplantation in Decompensated Cirrhosis: A Systematic Review on Safety and Efficacy
<b>Background and Aims:</b> Due to increasing knowledge of the "gut-liver axis", there has been growing interest regarding the use of fecal microbiota transplant in the management of chronic liver disease. There are limited data available and current guidelines are mostly based...
Saved in:
Main Authors: | Annie S. Hong (Author), Kyaw Min Tun (Author), Jenny M. Hong (Author), Kavita Batra (Author), Gordon Ohning (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
by: Chang Mo Moon, et al.
Published: (2021) -
Fecal Microbiota Transplantation: Is It Safe?
by: Seon-Young Park, et al.
Published: (2021) -
Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews
by: Di Zhang, et al.
Published: (2023) -
Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
by: Da Zhou, et al.
Published: (2023) -
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
by: Kelly L. Hayward, et al.
Published: (2021)